Overview
Pulmonary rehabilitation (PR) is a "comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies that include, but are not limited to, exercise training, education, and behavior change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors" (1) . PR reduces patients' symptoms; improves limb muscle function, exercise capacity, emotional function, quality of life, knowledge, and self-efficacy; has health economic benefits (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) ; and is an essential component of the integrated care of patients with chronic respiratory diseases. However, despite its clear benefits, PR is grossly underutilized and is frequently inaccessible to patients. Insufficient funding; limited resources for PR programs; inadequate allocation of health system reimbursement for PR; lack of healthcare professional, payer, patient, and caregiver awareness and knowledge regarding the process and benefits of PR; suboptimal use of PR by suitable patients (13, 14) ; and limited training opportunities for PR professionals all contribute to the gap between the science and benefits of PR (1, 11, 15) and the actual delivery of PR services.
Details of the science and delivery of PR were highlighted in the 2013 American Thoracic Society/European Respiratory Society Statement on PR (1) . This new Policy Statement has a different focus: it provides policy recommendations with the principal objective of expanding the provision of PR to suitable individuals worldwide. It represents the consensus of international experts in the field of PR, experts in primary care, and international patient advocates. It provides recommendations that address key processes central to achieving our objectives of enhancing implementation, use, and delivery of PR, including increasing healthcare professional, payer, and patient awareness and knowledge of PR; increasing patient access to PR; and ensuring quality of PR programs. It also provides suggestions for actionable items that will foster implementation of the policy recommendations. Noteworthy policy recommendations to increase implementation, use, and delivery of PR that are discussed in this statement include the following:
d Physician and allied healthcare professional trainees who treat patients with chronic respiratory diseases should have formal training in the science, process, and benefits of PR. Training requirements should be specified in national training curriculum documents, and consistency should be maintained in programs for each healthcare discipline and across disciplines. (15, 50) ; it is frequently not included in the integrated care of patients with chronic respiratory disorders and is often inaccessible to patients. Indeed, a substantial gap exists between knowledge regarding the science and benefits of PR (11, 12, 15) and the actual delivery of PR services (15, 50) . Reasons for this gap include: insufficient funding; limited resources for PR programs; inadequate allocation of health system reimbursement for PR; lack of healthcare professional, payer, patient, and caregiver awareness of and knowledge regarding the process and benefits of PR; suboptimal use of PR by suitable patients (13, 14) ; and limited training opportunities for PR professionals. These issues appear to be worldwide in scope (15) . Importantly, also, although intensive inpatient rehabilitation services for the sickest patients are widely distributed, availability of outpatient or community-based PR programs is insufficient or lacking in many geographic areas. Moreover, within and among countries, PR is heterogeneous regarding program structure, content, staffing, available resources, and patient referral practices (15, 50, 51 
Background: PR
Patients with chronic respiratory diseases experience disabling symptoms (including dyspnea and fatigue) and exercise intolerance, have low physical activity levels, and report impaired quality of life (4, (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) . The tremendous burden posed by these issues often persists despite optimal pharmacologic treatment. Moreover, persons with respiratory diseases have heterogeneous features, and, for many, extrapulmonary manifestations such as skeletal muscle dysfunction (62-69) and medical and psychological comorbidities (such as anxiety and/or depression) are key contributors to their symptoms and functional limitations (70) (71) (72) (73) . PR, as defined in the 2013 Official ATS/ERS Statement, is "a comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies that include, but are not limited to, exercise training, education, and behavior change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors" (1, 12) . It emphasizes stabilization and/or reversal of extrapulmonary manifestations and comorbidities of chronic respiratory disease as well as the importance of behavior change. PR is an essential component of an integrated continuum of healthcare across the trajectory of the patient's illness as well as across healthcare providers and venues. It is not a new therapy; the first official ATS consensus statement on its application was published in 1981 (74) . Major recent advances in the science and delivery of PR were highlighted in the 2013 ATS/ERS PR Statement (1, 12) . The established benefits of PR are summarized in Table 1. PR is beneficial throughout the course of disease for symptomatic medically stable patients with COPD (75) and other chronic respiratory disorders (11) , and supervised, center-based PR is also effective during or soon after acute exacerbations of COPD (76, 77) . Comprehensive PR has similar benefits when delivered in inpatient, outpatient, and community-based settings (7, 10, 78, 79) . Generally, a minimum of 8 weeks (two to three sessions per week) of outpatient or community-based treatment (or comparable number of contact hours) is needed to achieve an effect on exercise performance and quality of life (1, 12, 15, 80) ; longer programs may produce greater gains (12, 80, 81) , and repeat courses yield benefits of equivalent magnitude to those of first-time participation (82) . Exercise training is the cornerstone component of PR. Concurrent behavioral interventions, such as promoting self-efficacy and teaching collaborative self-management skills, are also integral to optimizing patient outcomes (83, 84) . Patients graduating from a PR program stand to benefit from a home, community-based, or programbased maintenance exercise program to support the continuation of positive exercise behavior (85). Patients will not receive PR unless they are referred, which is unlikely to occur unless healthcare professionals (including primary care and specialist physicians, nurse practitioners, physician associates, and allied health professionals) are aware of the existence of PR and have knowledge of its benefits. Suboptimal healthcare professional awareness of PR is currently a barrier to patient referral (86) . Healthcare trainees. Awareness of PR should ideally begin during training. Currently, exposure to the processes, indications, and benefits of PR are generally not a mandatory part of the education of physicians, nurse practitioners, physician associates, or allied healthcare professionals. Although detailed recommendations for training in PR exist in some countries, such as the UK (87), even for pulmonary physicians, stated training requirements are often vague or limited. This is true in the United States (88), Canada (89), the Netherlands (90), Australia (91), and Latin America (92). Furthermore, primary care and other healthcare professionals, who provide care for the majority of patients with respiratory disease, often have very little if any exposure to PR in the course of their training. Some postgraduate training is available (Table 2 ), but it is not mandatory, is often not standardized, and is at the discretion of the healthcare professional. There is a clear need for enhanced and more standardized exposure to PR within existing healthcare professionals' training programs.
Healthcare professionals in clinical
practice. There is a need for more education and learning opportunities for established practicing primary and specialty care physicians, nurse practitioners, physician associates, and other allied healthcare professionals about the process and benefits of PR. Increased knowledge of PR could foster dialogue between healthcare professionals and their patients, thereby promoting referrals to PR. Recommendations for increasing healthcare professional awareness and knowledge of PR are provided in Boxes 1 and 2.
Payer Awareness and Knowledge PR is one of the most cost-effective treatment interventions available for patients with chronic respiratory diseases (93) (94) (95) (96) (97) and is associated with a substantial reduction in hospitalizations, other urgent healthcare resource use, and healthcare costs (76, 93-95, 98, 99) . For example, its value is situated favorably within the context of other components of therapy for COPD in the UK (Figure 1 ) (96, 97); the relative value costs are not yet studied in non-COPD chronic respiratory disorders. Nevertheless, payer awareness of PR is often poor, and funding of PR is inadequate. Adequate funding is vital to PR program availability, capacity, effectiveness, and viability. Although heterogeneous payment structures and resources exist within and across countries (15) , increasing payer knowledge is the first step toward securing adequate long-term funding.
Informal discussions with representatives from government and private insurance payers in several continents as part of development of this document suggested their perception that current funding and reimbursement for PR are adequate. However, the existence of payer-related barriers is supported by a published survey in the UK (93) and by an informal survey conducted by members of the Task Force for this document (Table E2 ). These surveys point to an inadequate appreciation among payers of the clinical effectiveness and cost-effectiveness of PR. To this end, increased dialogue and effective
Box 1: Increasing Healthcare Professional Trainee Awareness and Knowledge of PR

Recommendations:
d Physician and allied healthcare professional trainees who treat patients with chronic respiratory diseases should have core formal training in PR, including its scientific rationale, process, and benefits. This includes use of training modules covering the topics shown in Table 3 and provision of practical "hands-on" experiences. d Training requirements should be specified in national training curriculum documents, and consistency should be maintained in programs for each healthcare discipline and across disciplines.
Actionable Items:
d Educational authorities from respiratory, primary care, nursing, and other allied healthcare professionals' societies collaborate to develop specific curricula for PR training for their respective healthcare trainees. d Respiratory, primary care, and allied healthcare professionals' societies establish national training program curricular registries to coordinate and monitor progress toward curricula development. Respiratory disease societies and PR providers, in collaboration with primary care health professional groups and patient advocacy groups:
B Develop methods of detailing the benefits, costs, and value of PR to be communicated to payers. B Enhance platforms and assure increased resources for communicating the effectiveness of PR to payers. B Develop a coordinated advocacy strategy to facilitate incorporation of PR into healthcare systems and practices as a "standard of care" component of the overall integrated care of patients with chronic respiratory diseases. 
Box 4: Increasing Patient Awareness and Knowledge of PR
Recommendations:
d Professional societies and patient advocacy and education experts should collaborate in the development of language, education level, and culturally appropriate education materials in multiple formats (e.g., written, internet based) for patients with chronic respiratory diseases, to enable them to knowledgeably advocate for access to PR. d Healthcare professionals should provide information regarding the process and benefits of PR to suitable patients. d Communication campaigns should be addressed to the general public regarding the process and benefits of PR.
Actionable Items:
d Professional societies such as the ATS, ERS, and others partner with national and international patient advocacy groups to prepare and disseminate PR-related educational materials culturally adapted to each country and compatible with patient health literacy, and to ensure that educational messages are consistent in the materials for healthcare professionals, patients, and families. d Professional societies such as the ATS and ERS and patient advocacy groups disseminate the above-noted educational materials to hospitals, clinics, community centers, and patient support groups and make them available online. d Develop media campaigns with governmental and professional societies' support to increase the awareness of patients and the general public regarding the benefits of PR, exercise, and physical activity. d PR providers within professional societies such as ATS and ERS advocate that pharmaceutical companies with access to patients spread awareness of the existence and benefits of PR in combination with other therapies (including pharmacotherapy and supplemental oxygen).
adding PR as a treatment option within existing cardiac or general rehabilitation programs, or adding additional essential components of PR (besides exercise training that constitutes the cornerstone of every PR program), such as self-management training and patient education, to interventions composed solely of exercise training could also increase program capacity and patient access to PR. A significant increase in funding support for PR will be needed to address each of these issues.
Geographic Inaccessibility
Worldwide, access to PR is limited in many geographic areas, and in some countries PR programs are lacking altogether (15, 102) . Patients frequently cite distance and lack of transportation as a major reason for poor program uptake or adherence (14) . It is known that travel time greater than 30 minutes is a barrier to patient participation in PR (103) . These factors should be considered when new PR programs are established.
Improving Access to PR for Persons with Non-COPD Respiratory Disorders
PR has demonstrated effectiveness for several respiratory conditions other than COPD (2, 11) . Randomized controlled trials demonstrating its beneficial effects on exercise capacity, symptoms, and/or healthrelated quality of life are available in interstitial lung disease, bronchiectasis, asthma, cystic fibrosis, lung transplantation, lung cancer, and pulmonary hypertension (16-30, 32-34, 36, 38-40, 42, 43, 45, 46, 104) . There may be special considerations and additional training for PR staff required when including persons with non-COPD disorders (3, 11, 12 
Limitations on PR Eligibility over Time
The benefits of 8 to 12 weeks of PR typically last up to 12 months (17, 21, 119 ). Yet, patients live with their chronic respiratory diseases over the course of their lifetime. Emphasis is placed in PR programs on health-enhancing behavior change for this reason. Nevertheless, a nihilistic view toward PR is often taken by payers and healthcare professionals as a result of a potentially limited duration of the benefits resulting from patients' participation in a single PR program course. In some countries (e.g., the United States), there is a payer limit on the total number of PR sessions patients can attend. This is counterproductive, because repeat courses of PR afford similar benefits to those of initial patient participation (82) and, at least for COPD, PR is effective after acute disease exacerbations (76, 120) , which are associated with worsened symptoms, functional decline, and high healthcare costs (121) (122) (123) . Increasing patients' access to PR, including repeated courses where clinically indicated, has the potential to improve patients' health over the course of their lives and to reduce healthcare use costs.
Patient-Level Barriers to PR
Patients referred to PR consistently report barriers to initiation of and adherence with the intervention (13, 14) , and up to half of eligible patients referred to PR never attend (14) . In addition to travel and transportation issues, lack of support from family members or other caregivers, depression, comorbid illness, and disruption of daily routine are particularly important (14) . Members of the Task Force for this Policy Statement also conducted an informal survey of patients' opinions regarding access to PR among members of ATS' Public Advisory Roundtable, ELF's patient organization network, the COPD Foundation, and the Pulmonary Fibrosis Foundation. Responses from patients with a wide variety of chronic respiratory conditions were included. Key patient-identified barriers to accessing PR identified in a survey of 1,686 respondents from 29 countries ( Figure E1 ) included (in descending order of frequency) lack of awareness of PR ("never heard of it"), insufficient information on process or potential efficacy, lack of available PR services, and lack of insurance coverage. The findings of this patient survey corroborate the issues regarding awareness and knowledge of PR and access to PR discussed above. Importantly, many of these barriers seem modifiable with orchestrated actions.
Limited Number of PR Healthcare Professionals
Trained PR healthcare professionals are necessary for provision of PR to patients. Availability of education, training, and funding for healthcare professionals who strive to become PR providers varies within and across countries. Although formal documentation is lacking, insufficient availability of PR providers has the potential to limit patient access to PR. Recommendations for increasing patient access to PR are provided in Box 5.
Ensuring Quality of PR Programs
The quality of PR programs is reflected in process and performance metrics. The 2013 ATS/ERS PR Statement, the 2013 British Thoracic Society quality standards, and other documents (1, 3, 6, 10, 12, 93, 116, 117) summarize the evidence underpinning best practice for PR. Program certification is a means of ensuring standards are met.
AMERICAN THORACIC SOCIETY DOCUMENTS
Currently, only the American Association of Cardiovascular and Pulmonary Rehabilitation (in the United States) (2) and some countries in Europe (124) offer this certification process. Implementation of a similar internationally relevant process that evaluates PR program quality and rewards quality programs is needed. This would facilitate highlighting and dissemination of quality standards for PR programs to healthcare facilities, healthcare professionals, and policy makers. To qualify as PR, programs must include, at a minimum: a structured and supervised exercise program for patients with a variety of respiratory conditions, a patient education/ behavioral program intended to foster healthenhancing behavior, patient assessment and outcomes measures, and provision of recommendations for home-based exercise and physical activity (1, 3, 5, 7, 10, 12, 93, (125) (126) (127) (128) . Staff of PR programs must have demonstrated competencies in provision of PR (101) . They must also be aware of and be prepared to work closely with other healthcare professionals to handle the multimorbidity present among persons referred for PR, including the psychological impact and manifestations of chronic respiratory disease. To be universally applicable, these program components must be implemented with consideration of local resources, as well as cultural, economic, and healthcare system differences across countries. The health economic benefits of PR can potentially be further enhanced by using the program as a vehicle to promote increased daily physical activity, which may in turn reduce the risk of hospital admission (129) .
The quality of PR programs is demonstrated by their success in improving patient outcomes. Patients entering PR programs are heterogeneous regarding disease state, symptoms, functional limitations, medical comorbidities, and psychologic burden of disease. Patient assessments conducted at the start of PR characterize patients to enable delivery of individualized rehabilitation according to each patient's needs. To assess program quality, clinical outcomes must be measured for individual patients and presented in aggregate. Essential outcomes measurements in PR include, at a minimum, the standardized assessment of patients' functional exercise capacity, dyspnea, and health status (1-3, 6, 10, 12) . Several disease-relevant methods are available for measuring these outcomes (11, 12) . Assessment of additional multidimensional outcomes (considered further in the 2013 ATS/ERS Statement on Pulmonary Rehabilitation) (1), including (but not limited to) impact of PR on psychological comorbidity and measures of the patient experience, is desirable, because patients' responses to PR are multidimensional (130) . The selection and standardization of outcome measures for the purpose of program comparison and benchmarking will vary among different jurisdictions, but should be guided by the d Patient access to PR should be improved by augmenting program commissioning through increased sustainable payer funding. d New PR programs should be created in geographic areas where demand exceeds capacity. d Novel PR program models should be developed and studied that will make evidence-based PR more accessible and acceptable to patients and payers; this may include new approaches within hospital-based programs, community-based programs, comprehensive and wellresourced home-based or telehealth-supported programs, or other novel models of program delivery. d Selection criteria for PR should reflect current published evidence. The evidence indicates that patients who benefit from PR include not only persons with moderate to severe airflow limitation but also those with mild to moderate airflow limitation with symptomlimited exercise tolerance, those after hospitalization for COPD exacerbation, and those with symptomatic non-COPD respiratory conditions. Increasing patient access for these patient groups will depend on increased referrals, increased payer funding, and patient demand for services.
d PR providers systematically detail and document the costs of providing comprehensive quality PR services and share this information with those advocating PR policies' reimbursement rate to facilitate appropriate and necessary reimbursement. d Identify the number of patients potentially suitable for PR (based on outpatient and hospital discharge databases) within local and regional jurisdictions to assess the need for establishment of new PR programs and/or increased capacity of existing programs. d PR providers, local funding agencies, health systems, patients, and researchers collaborate to establish the optimal models that will increase PR capacity and uptake. d Professional societies (such as ATS, ERS, and others) audit existing patient selection criteria for PR and work with accreditation organizations to broaden patient candidacy to include those with symptomatic non-COPD respiratory conditions, those after hospitalization for COPD exacerbation, and symptomatic patients with mild to moderate airflow limitation. d Professional respiratory societies (such as ATS, ERS, and others) audit the availability of PR providers and training programs for healthcare professionals who strive to become PR providers. d Patients and their families partner with healthcare professionals, advocacy groups, and health professional societies to petition for greater capacity and access to PR in terms of the numbers of programs, patient eligibility, and insurance coverage. d PR programs identify local barriers to patient uptake and adherence to PR and outline strategies to address these barriers. d Payers offer incentives for suitable patients to participate in PR. d Payers link healthcare professionals' patient referrals to PR to "pay for performance." AMERICAN THORACIC SOCIETY DOCUMENTS respiratory scientific community based on disease-relevant published evidence. Providers should be encouraged to quantify the economic benefits of patient participation in PR (e.g., reductions in hospital admissions) where possible.
Evidence of safety should be assessed based on standard operating policies, risk assessments, and critical incident reporting. PR program directors should conduct an annual internal audit of program process and outcomes. PR programs should also collect and respond to information on patient experience, needs, and satisfaction before, during, and after PR. Quality standards for PR should be consistent across programs, but solutions to achieve these standards must be appropriate to the locale, to ensure the best care of patients in a cost-effective manner.
Long-term adherence to healthenhancing behaviors, such as exercise, physical activity, abstinence from smoking, and immunization, is a key goal of PR. Although the optimal means of maintaining benefits achieved in PR is not fully clear (85, 131) , PR professionals' efforts to assist patients in continuing to adhere to exercise, incorporating knowledge gained in PR into daily living, and maintaining collaborative interaction with healthcare professionals over the long term are essential. Involvement of home caregivers and close collaboration and coordination of care between patients, PR professionals, and patients' other healthcare providers are crucial to achieve these goals.
Recommendations for ensuring quality of PR programs are provided in Box 6.
Future Research To Advance Evidence-based Policy in PR
Although the scientific rationale for PR is established, and the evidence of the benefits d Further research should be undertaken regarding the cost-effectiveness of PR: this may include innovative models of PR delivery, sites and/or timing of PR, PR for respiratory disorders other than COPD, and repeat courses of PR over time. d Further investigation of alternative models of providing PR should be undertaken to improve access and uptake, using program models of known efficacy. d Further investigation of alternative models of providing PR should be undertaken to address the needs of patients with a high burden of psychological and multiple medical comorbidities. d Further research should be done regarding barriers and facilitators of PR program referrals, accessibility, enrollment, and adherence for persons with chronic respiratory diseases. d Further research should be undertaken to assess the impact of PR program funding source on patient use of PR.
Actionable Items:
d PR experts articulate and document priorities for PR-related research within PR assemblies of professional organizations such as ATS and ERS and communicate them to patient advocacy groups and funding agencies via stakeholder forums and workshops. d PR experts lobby professional societies as well as patient advocacy organizations and federal agencies to direct current and future funding toward PR research. d Healthcare professionals conduct pragmatic, "real-world" trials of PR.
Box 6: Ensuring Quality of PR Programs
Recommendations:
d PR programs should follow relevant evidence-based clinical guidelines and demonstrate the measurement of standard outcomes, to document benefits, quality, and safety. d A core set of processes and outcomes should be established to enable national and international benchmarking in PR; this should include both process and performance metrics to enable recommendations for international standards based on evidence and best practice. d PR programs should encourage and foster patients' long-term adherence to health-enhancing behaviors to optimize patient wellness and reduce healthcare costs. 
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of PR for persons with COPD and other forms of chronic respiratory disease is extensive and convincing, there are several areas wherein further knowledge is needed (Table E3 ) (12) . Importantly, the Task Force for this Policy Statement identifies key areas for future research that will impact commissioning policy for PR and will in turn have potential to augment delivery of PR services and patient access to PR.
Although the traditional models of inpatient and outpatient PR are suitable for many patients, alternative models may also be effective and may improve patient access, particularly in regions or healthcare systems where traditional models of PR are not feasible. For example, tele-rehabilitation, which links expert rehabilitation healthcare providers with others at a remote site or with patients in their homes, also has potential to improve access. Initial small-scale studies demonstrate feasibility and suggest that clinical benefits may be achieved (132) (133) (134) (135) . Carefully structured home-based exercise training and rehabilitation that is supported by PR program staff with or without specialized exercise equipment might be feasible in some healthcare environments (136, 137) . Alternate methods for components of exercise training (such as use of elastic resistance tubes rather than specialized equipment for resistance training) (138) may be applicable across a broad range of settings. Robust research is underway in these areas (139) , and further work is needed to validate these approaches. Adoption of alternative models for PR will require demonstration of comparable or greater clinical outcomes to those of traditional PR programs, as well as evaluation of safety and cost-effectiveness, staff training, and guideline development. Thus, to move the field forward, more funding for PR research in these areas will be needed.
More information is also needed regarding the clinical and economic benefits of repeat courses of PR (especially for patients with chronic respiratory disorders other than COPD) and regarding optimal strategies for managing medical and psychological multimorbidity in the context of PR. Also, although the impact of funding source on patient use of PR is unclear, sources of funding for PR programs and reimbursement for patient participation vary widely, and this may in turn impact patient enrollment and participation (15) . Young healthcare professionals will also require encouragement and an increase in infrastructure to enable them to pursue careers as clinician investigators with a focus on PR. Recommendations for future research to advance evidence-based policy in PR are provided in Box 7. 
